Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
World Journal of Urology|December 20, 2017
Fuhrman grading is inappropriate for papillary renal cell carcinomaBrett Delahunt, Lars Egevad, John R Srigley, et al.
Urologic Oncology|October 1, 2016
New Gleason grading system: Statement from the editors of 6 journalsLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
Histopathology|December 20, 2018
Grading of renal cell carcinomaBrett Delahunt, John N Eble, Lars Egevad, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
In Regard to Zietman et alLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
European Urology|July 28, 2016
Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1Lars Egevad, Hemamali Samaratunga, John R Srigley, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 7, 2016
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary gradingLars Egevad, Brett Delahunt, John R Srigley, et al.
The Journal of Urology|July 25, 2016
Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016;195: 1723Lars Egevad, Hemamali Samaratunga, John R Srigley, et al.
European Urology|November 27, 2015
Utility of Reporting the Percentage of High-grade Prostate CancerLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Urology|September 6, 2016
Reply by the AuthorsLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
Analytical and Quantitative Cytology and Histology|April 28, 2006
Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significanceHemamali Samaratunga, Robert A Gardiner, John Yaxley, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
World Journal of Urology|December 20, 2017
Fuhrman grading is inappropriate for papillary renal cell carcinomaBrett Delahunt, Lars Egevad, John R Srigley, et al.
Urologic Oncology|October 1, 2016
New Gleason grading system: Statement from the editors of 6 journalsLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
Histopathology|December 20, 2018
Grading of renal cell carcinomaBrett Delahunt, John N Eble, Lars Egevad, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
In Regard to Zietman et alLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
European Urology|July 28, 2016
Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1Lars Egevad, Hemamali Samaratunga, John R Srigley, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 7, 2016
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary gradingLars Egevad, Brett Delahunt, John R Srigley, et al.
The Journal of Urology|July 25, 2016
Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016;195: 1723Lars Egevad, Hemamali Samaratunga, John R Srigley, et al.
European Urology|November 27, 2015
Utility of Reporting the Percentage of High-grade Prostate CancerLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Urology|September 6, 2016
Reply by the AuthorsLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
Analytical and Quantitative Cytology and Histology|April 28, 2006
Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significanceHemamali Samaratunga, Robert A Gardiner, John Yaxley, et al.
Pageof 19